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First Head-to-Head Comparison of Effective Radiation Dose
from Low-Dose CT with Prospective ECG-Triggering versus
Invasive Coronary Angiography
Abstract
BACKGROUND: Reduction of radiation burden of multidetector CT coronary angiography (CTCA)
has remained an important task. OBJECTIVES: To compare effective radiation dose of low-dose
64-slice CTCA using prospective ECG-triggering versus diagnostic invasive coronary angiography
(CA). METHODS: Forty-two patients referred for elective invasive CA due to suspected coronary artery
disease (CAD) were prospectively enrolled to undergo a low-dose CTCA without calcium scoring
within the same day prior to CA. Dose-area product of diagnostic invasive CA and dose-length product
of CTCA were measured, converted into effective radiation dose and compared using Man-Whitney-U
tests. In addition, accuracy of CTCA to detect CAD (coronary artery narrowing >/= 50%) was assessed
using invasive CA as standard of reference. On an intention-to-diagnose-base all non-evaluative vessels
were included in the analysis and censored as positive. RESULTS: The estimated mean effective
radiation dose was 8.5 +/- 4.4mSv (range: 1.4 - 20.5mSV) for diagnostic invasive CA, and 2.1 +/-
0.7mSv (range: 1.0 - 3.3mSv) for CTCA (P<0.001). Nineteen patients (42.9%) had no CAD by invasive
CA. Forty (95.2 %) patients have been correctly classified as having CAD (23/23) or no CAD (17/19).
Over 97 % (551/567) of segments were evaluable. Vessel-based analysis revealed sensitivity,
specificity, positive and negative predictive value of 94.2 % (CI: 0.8-1.0), 94.8% (CI: 0.9-1.0), 89.0%
(CI: 0.8-1.0), 97.4% (CI: 0.9-1.0), and an accuracy of 94.6%. CONCLUSIONS: Low dose CTCA
allows evaluation of CAD with high accuracy, but significantly less effective radiation dose to patients
compared to diagnostic invasive CA.
doi:10.1136/hrt.2008.162420 
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ABSTRACT 
Background: Reduction of radiation burden of multidetector CT coronary 
angiography (CTCA) has remained an important task. 
Objectives: To compare effective radiation dose of low-dose 64-slice CTCA using 
prospective ECG-triggering versus diagnostic invasive coronary angiography (CA). 
Methods: Forty-two patients referred for elective invasive CA due to suspected 
coronary artery disease (CAD) were prospectively enrolled to undergo a low-dose 
CTCA without calcium scoring within the same day prior to CA. Dose-area product of 
diagnostic invasive CA and dose-length product of CTCA were measured, converted 
into effective radiation dose and compared using Man-Whitney-U tests. In addition, 
accuracy of CTCA to detect CAD (coronary artery narrowing ≥ 50%) was assessed 
using invasive CA as standard of reference. On an intention-to-diagnose-base all 
non-evaluative vessels were included in the analysis and censored as positive. 
Results: The estimated mean effective radiation dose was 8.5 ± 4.4mSv (range: 1.4 
– 20.5mSV) for diagnostic invasive CA, and 2.1 ± 0.7mSv (range: 1.0 – 3.3mSv) for 
CTCA (P<0.001). Nineteen patients (42.9%) had no CAD by invasive CA. Forty 
(95.2 %) patients have been correctly classified as having CAD (23/23) or no CAD 
(17/19). Over 97 % (551/567) of segments were evaluable. Vessel-based analysis 
revealed sensitivity, specificity, positive and negative predictive value of 94.2 % (CI: 
0.8-1.0), 94.8% (CI: 09-1.0), 89.0% (CI: 0.8-1.0), 97.4% (CI: 09-1.0), and an accuracy 
of 94.6%. 
Conclusions: Low dose CTCA allows evaluation of CAD with high accuracy, but 
significantly less effective radiation dose to patients compared to diagnostic invasive 
CA. 
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INTRODUCTION 
Since the implementation of 64 slice CT scanners, CT coronary angiography (CTCA) 
has developed to a non-invasive tool with high accuracy for the evaluation of 
coronary artery disease (CAD) [1]. However, effective radiation dose (E) to patients 
and its risk of cancer induction has remained an issue of concern, although only few 
quantitative data on dose-risk relation are available [2]. The latter is mainly based on 
epidemiologic studies from atomic bomb survivors from the Hiroshima and Nagasaki 
tumor registries, studies of persons exposed for medical reasons and studies of 
nuclear workers [3]. The risk of cancer from exposure to low levels of ionizing 
radiation, defined as effective dose below 1 and up to 100 mSv, may proceed in a 
linear fashion to increasing radiation dose without a lower threshold. Thus, small 
radiation doses to patients may cause a small increase of risk [3]. The American 
Heart Association states that a CT with an effective radiation dose of about 10mSv 
may be associated with an increase in the possibility of fatal cancer as recently 
published [4]. Brenner et al. estimated a lifetime cancer mortality risk of 0.08% 
attributable to a full-body CT scan with an effective radiation dose of 12mSv in a 45 
year-old male adult [5]. Although this may appear justifiable under certain clinical 
circumstances the risk may be higher in younger and female patients. Therefore, any 
successful reduction of radiation dose is important. By using ECG-modulation 
radiation burden of CTCA could be reduced from initially over 20 mSv [6] to 10-
15mSv [7], and with optimized protocols below 8 mSv [8]. A milestone in the 
reduction of E could be achieved by a new scanning protocol using prospective ECG-
triggering where radiation is administered only at one predefined end-diastolic time 
point instead of during a whole phase of the cardiac cycle [9]. First reports 
demonstrated the feasibility [10, 11] and latest results confirm maintained high 
diagnostic accuracy [12, 13] of this new technique.   
Although the United Nations Scientific Committee on the Effects of Atomic Radiation 
cites a typical value of about 7 mSv for E from invasive CA [14], no data on direct 
head-to-head comparison in the same patient between E from CTCA and CA are 
available.  
The aim of the present study was to assess E of diagnostic invasive CA and low dose 
CTCA using prospective ECG-triggering in the same patient. 
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PATIENTS AND METHODS 
Study population 
Among 74 consecutively screened patients with no known CAD, 9 patients refused to 
give the consent and could, therefore not be included. Of the 65 enrolled patients 14 
deemed ineligible due to renal insufficiency (creatinine levels >150 μmol/l, or >1.7 
mg/dl) (n = 8); allergy to iodinated contrast agent (n = 3), non sinus rhythm or known 
premature ventricular or supraventricular beats (n = 12). The final study population 
consisted of 42 prospectively enrolled patients, different from patients included in 
previously reported studies on the feasibility [11] and accuracy [12] of low dose 
CTCA with prospective ECT-triggering. The pre-test probability for CAD was 
estimated using the Duke Clinical Score, which includes the type of chest discomfort, 
age, gender, and traditional risk factors [15]. All patients where referred for elective 
invasive CA because of suspected CAD with the following symptoms: dyspnoea (n = 
9), typical angina pectoris (n = 7), atypical chest pain (n = 19) and pathological 
exercise test or ECG (n = 14). CTCA and invasive CA were successfully performed in 
all 42 patients (29 male, 12 female; age 62 ± 8.4 years, range: 42 to 82 years) on the 
same day. Thirteen patients were on betablocker therapy as part of their baseline 
medication. Additional intravenous metoprolol (2 to 20 mg) (Beloc, AstraZeneca, 
London, UK) were administered for heart rate control prior to CTCA in 22 patients 
(mean 5.7 ± 6.6 mg) yielding a mean heart rate of 55.4 ±  6.2 bpm (range: 36 – 70 
bpm) and a mean heart rate variability of 1.6 ± 1.7 bpm (range: 0.3 – 9.7 bpm). The 
mean BMI was 26.9 ± 4.4 kg/m2 (range: 18.6 – 44.8 kg/m2). The study protocol was 
approved by the local ethics committee and written informed consent was obtained.  
 
Data acquisition and post-processing 
All patients received a single dose of 2.5 mg isosorbiddinitrate sublingual (Isoket, 
Schwarz Pharma, Monheim, Germany) 2 minutes prior to the scan. In addition, 
intravenous metoprolol was administered, if necessary to achieve a target heart 
below 65 bpm prior to the start of the scan. Heart rate was monitored and heart rate 
variability was assessed as the standard deviation of the heart rate throughout the 
scan as previously reported [16]. For CTCA, 80 ml of iodixanol (Visipaque 320, 320 
mg/mL, GE Heathcare, Buckinghamshire, UK) at a flow rate of 5 ml/s followed by 50 
ml saline solution was injected into an antecubital vein via an 18-gauge catheter. 
Bolus tracking was performed with a region of interest placed into the ascending 
aorta, and image acquisition was started 4 s after the signal density reached a 
threshold of approximately 120 Hounsfield units. All CTCA examinations were 
performed with a LightSpeed VCT XT scanner (GE Healthcare) and prospective 
ECG-triggering [9] using a commercially available protocol (SnapShot Pulse, GE 
Healthcare) and the following scanning parameters as previously reported [11]: slice 
acquisition acquisition 64 × 0.625 mm, smallest x-ray window (only 75% of the RR-
cycle, setting the padding to 0 ms), z-coverage 40 mm with an increment of 35 mm, 
gantry rotation time 350 ms, body mass index (BMI) adapted tube voltage (100 kV: 
BMI < 25 kg/m2, 120 kV: BMI ≥ 25 kg/m2) and effective tube-current (450 mA: BMI < 
22.5 kg/m2, 500mA: BMI 22.5 – 24.9 kg/m2 , 550 mA: BMI 25.0 - 27.4 kg/m2, 600 mA: 
BMI 27.5 - 30 kg/m2, 650 mA: BMI >30 kg/m2). The CT scan was performed from 
below the tracheal bifurcation to the diaphragm, choosing 3 to 4 scan blocks (field of 
view 11 to 14.5 cm). By restricting the scan to the smallest possible window at only 
one distinct end-diastolic phase of the RR-cycle (i.e. 75%) we ascertained the lowest 
achievable effective dose delivery. CTCA images were reconstructed with a slice 
thickness of 0.6 mm, using a medium-soft tissue convolution kernel (standard). In 
case of vessel wall calcifications, additional images were reconstructed using a 
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sharp-tissue convolution kernel (detail) and preferably analyzed using a bone window 
setting (window width: 1500 HU; window level: 500 HU) to compensate for blooming 
artifacts. All images were transferred to an external workstation (AW 4.4, GE 
Healthcare). 
 
CT image analysis 
Coronary arteries were segmented as suggested by the American Heart Association 
[17]. The right coronary artery (RCA) was defined to include segments 1-4, the left 
main artery (LMA) to include segment 5, the left anterior descending artery (LAD) to 
include segments 6-10, and the left circumflex artery (CX) to include segments 11-16; 
the intermediate artery was designated as segment 16, if present. All segments with 
a diameter of at least 1.5 mm at their origin were included. Step artifacts at junctions 
of different image blocks may not necessarily lead to misinterpretations. However, as 
a hidden lesion within the artifact cannot be excluded with absolute certainty we have 
categorized any step artifact as non-evaluative. On an intention–to-diagnose-base all 
non-evaluative segments classified the whole vessel as not evaluative which was 
censored as positive and included in the final analysis. Two readers experienced in 
cardiac radiology assessed all coronary vessels for the presence of hemodynamically 
significant stenoses, defined as narrowing of the coronary luminal diameter ≥ 50 %. 
In case of multiple lesions in one segment, the segment was classified by the worst 
lesion. For any disagreement in data analysis between the two observers, consensus 
agreement was achieved. 
 
Invasive coronary angiography 
Invasive CA through the femoral artery was performed on an Allura 9 and an Allura 
XPER FD10/10 (Philips Medical Systems) catheterization equipment in an 
experienced catheterization laboratory of a teaching hospital (University Hospital 
Zurich) following a protocol which consists of a biplane angiography of the left 
coronary artery with two radiation exposures in four orientations and of the right 
coronary artery with two exposures in two orientations, as is routinely performed in 
our cardiology department. With one tube, the left coronary artery was imaged in the 
following orientations: posteroanterior, 30° right anterior oblique with 20° caudal 
angulation, and 15° right anterior oblique with 30° cranial angulation. With the other 
tube, the left coronary artery was imaged in the following orientations: 90° left 
anterior oblique, 40° left anterior oblique with 20° cranial angulation, and 50° left 
anterior oblique with 60° caudal angulation. Angiography of the right coronary artery 
was performed in the following orientations: 30° right anterior oblique and 15° left 
anterior oblique with 15° cranial angulation with one tube, and 60° left anterior 
oblique and 90° left anterior oblique with the other tube. 
Additional views could be performed a t the operator discretion if necessary. In cases 
where a left ventricular angiogram was performed this part of radiation exposure was 
excluded. An experienced observer blinded to the results from CTCA evaluated the 
angiograms. Coronary arteries were included in the analysis if luminal diameter was 
at least 1.5 mm; excluding those vessels distal to complete occlusions. Each vessel 
was visually scored as being normal or significantly stenosed (defined as a diameter 
reduction of 
≥ 50 %) reflecting daily clinical routine in our catheterization laboratory. 
 
Effective radiation dose estimation (E) 
Values for E were estimated for CTCA as product of the dose-length product (DLP) 
times a conversion coefficient for the chest (k = 0.017 mSv / mGy x cm) as adapted 
by the European Commission in the European guidelines on quality criteria for 
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computed tomography [18]. Similarly E was estimated as product of the dose-area 
product (DAP) of the diagnostic coronary scenes times a conversion factor for chest 
(k = 0.22 mSv / mGy x cm) for invasive CA based on the National Radiological 
Protection Board tables [19]. 
 
Statistical analysis 
Quantitative variables were expressed as mean ± standard deviation and categorical 
variables or percentages. Man-Whitney-U tests were performed for comparison of 
effective radiation dose between CTCA and invasive CA in all patients and different 
BMI subgroups by using SPSS software (SPSS 15.0, Chicago, ILL, USA). A p-value 
of <0.0083 was considered as significant using the Bonferroni-adjustment for multiple 
testing. Sensitivity, specificity, positive predictive value (PPV), and negative 
predictive value (NPV) were calculated from Chi-Square tests of contingency. The 
95% confidence intervals (CI) and the positive and negative likelihood ratios (LR) 
were calculated. 
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RESULTS 
Effective radiation doses (E) 
For CTCA the mean DLP was 122.4 ± 42.1 mGycm, resulting in a mean E of 2.1 ± 
0.7 mSv. The variations of E between all patients (DLP: 58.5 – 193.2 mGycm, E: 1.0 
– 3.3 mSV) and within different BMI subgroups were small (fig. 1). 
For diagnostic invasive CA the DAP was 38.7 ± 4.4 mGycm2, resulting in a mean E of 
8.5 ± 4.4 mSv. The doses varied widely between all patients (DAP: 6.4 - 93.0 
mGycm2; E: 1.4 – 20.5 mSv) and within different BMI subgroups (fig. 1). There was 
no significant difference in E of invasive CA between patients with stenoses (mean: 
9.4 ± 4.4 mSv; range: 1.4 – 20.5 mSv) and those with no CAD (mean: 7.5 ± 4.3mSv, 
range: 2.0 – 14.7 mSv). 
Mean E was significantly higher in invasive CA versus CTCA in all analyzed patients 
(p<0.001) (fig. 2). The mean DLP, DAP and E for all patients and different BMI 
subgroups as well as their differences are given in table 1.   
 
Image quality with CTCA 
 Of 672 theoretically possible segments in 42 patients with 16 coronary segments, 64 
were missing due to anatomical variants, 33 had a diameter of less than 1.5 mm at 
their origin (by both methods) and 8 segments have been occluded. Thus, 64 
segments were missing for reasons not associated with the methodology as these 
segments did simply not exist. The remaining 33 segments were categorized as 
lower than 1.5 mm and thus not evaluable by the gold standard invasive CA. Thus, 
the missing data do not seem to introduce a selection bias. 
 Image quality of 551/567 segments (97.18 %) was diagnostic. Thus, sixteen 
segments (2.82 %) were non-diagnostic and were considered as positive. 
  
Diagnostic accuracy and impact of CTCA on pre-test probability 
In 23 (54.8 %) patients and 52 (31.0 %) vessels, 80 coronary artery stenoses were 
recognized with invasive CA. Nineteen patients (42.9 %) had no CAD by invasive CA. 
Forty (95.2 %) patients have been correctly classified as having CAD (23/23) 
(example: fig. 3) or no CAD (17/19) (example: fig. 4). 
On a per-vessel analysis, there was 94.2 % (49 / 52; CI: 0.8 – 1.0) sensitivity, 94.8 % 
(110 / 116; 95 % CI: 0.9 – 1.0) specificity, 89.0 % (49 / 55; 95 % CI: 0.8 – 1.0) 
positive predictive value (PPV), and 97.4 % (110 / 113; CI: 0.9 – 1.0) negative 
predictive value (NPV), yielding an accuracy at 94.6 % (CI: 09 – 1.0) (Table 2). 
On a per-patient analysis, there was 100 % (23 / 23; CI: 0.9 – 1.0) sensitivity, 89.5 % 
(23 / 25; CI: 0.7 – 1.0) specificity, 92.0 % (18 / 20, 95 % CI: 0.7 – 1.0) PPV, and 
100 % (17 / 17; CI: 0.8 – 1.0) NPV, yielding an accuracy of 95.2 % (CI: 0.8 – 1.0) 
(Table 2). The estimated pre- and post-test probabilities for significant CAD after 
CTCA scans are given in figure 5. 
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DISCUSSION 
While the gold standard for the detection of coronary lesions remains invasive CA, its 
associated costs [20],morbidity and mortality have driven the search for non-invasive 
alternatives like CTCA.  
However, radiation burden to patients has remained a concern and has led to 
hesitation against non-invasive cardiac imaging with CT, although introduction of tube 
modulation and optimized scanning parameters has allowed to decrease E of CTCA 
from over 20 mSv to below 10 mSv and may explain the large variability between 
different centers [8]. New scanner technologies such as dual-source [21] as well as 
latest scanner generations with 256 [22] and more slices [23] may allow the reduction 
of motions artifacts, the issue of radiation burden is not solved by these technical 
advances alone. In fact, in a preliminary study using 256 slices radiation administered 
to the patient has been reported as high as 33mSv [22]. 
 As the strength of CTCA lies in its ability to exclude CAD (i.e. its high NPV) the 
general perception is to use this technique mainly in low-to-intermediate probability 
populations [1]. The latter however will not only have a low prevalence of CAD but 
inherently also bear a low risk of cardiovascular events, which makes it unlikely that 
any diagnostic procedure or therapeutic intervention would further improve the 
outcome. This may explain why it seems to be a particular challenge for CTCA to 
keep a positive balance of harms and benefits. It is in this context that the recently 
introduced scanning protocol using prospective ECG-triggering - where scanning is 
limited to a narrow pre-defined end-diastolic phase resulting in a massive reduction in 
radiation exposure [11, 12] - was well received, as documented by a growing body of 
literature [13, 24, 25, 26, 27, 28, 29, 30, 31, 32]. The present paper is the first to 
report on the head-to-head comparison of E from invasive CA versus CTCA with 
prospective ECG-triggering in the same patients. Our results not only confirm the 
feasibility and reliability (accuracy versus invasive CA) of this low-dose CTCA 
protocol but also show that E is significantly lower by about 75% than in CA. This 
holds true for each individual patient and independently from the BMI and was not 
subject to a large inter-individual variability. By contrast E values from CA showed a 
large variability, in line with previous reports relating this variability to variances in 
procedure complexity, operator experiences or laboratory equipment [33]. In fact, in 
patients with complex coronary anatomy such as diffuse wall alterations and multiple 
lesions with intermediate severity or those with bypass grafts E from CA may 
increase considerably due to need of longer irradiation time, while the latter would not 
be affected using CTCA. Although in the present study we have excluded patients 
with known CAD thus eliminating patients with bypass grafts and reducing the 
probability of complex CAD we still found a significantly higher E from CA with a 
substantial inter-individual variance as opposed to CTCA. This strengthens our data 
supporting that the findings may remain valid even if extrapolated to various patient 
populations with different CAD probabilities.  
As the same field of view was used in virtually all patients the E from CTCA is mainly 
determined by the body physique because we used a BMI-adapted protocol for tube 
voltage and current. However, even after stratifying patients for BMI the variability of 
E from CTCA was negligible while it remained high for CA.  
Such a massive reduction in E achieved by using prospective ECG-triggering of 
CTCA may have a profound impact on the perception of the optimal patient 
population benefiting most from non-invasive CTCA. It is an accepted rule that for 
reasons of radiation protection the total dose applied to a given population should be 
kept as low as reasonably achievable (ALARA). This dramatically shifts the benefit to 
harm balance supporting the hypothesis that low-dose CTCA may serve as a 
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gatekeeper to CA in patient populations with CAD prevalence anywhere below 75%. 
Outcome trials are needed to establish whether such a strategy may improve 
outcome. Theoretically, for each saved CA due to a normal CTCA (saved dose 6 
mSv) we can afford 3 patients with CTCA plus CA (added dose of 2 mSv compared 
to CA alone). The use of CTCA as gate keeper reaches a break-even with regard to 
radiation exposure of the patient population with a prevalence of 75 %. The fact that 
the accuracy of CTCA does not reach 100 % may negatively affect this balance. On 
the other hand preventing an unnecessary CA may confer more benefits than just 
reducing total radiation exposure as even elective purely diagnostic CA are 
associated with a low but not negligible morbidity and mortality. In addition, findings 
of coronary luminal narrowing often trigger coronary interventions which are 
associated with an even higher mortality despite no proven outcome benefits in 
chronic stable CAD patients [34]. The values of E clearly favour CTCA over CA, 
although the conversion factor for estimating E from DLP in CA may be affected by a 
10 to 20 % uncertainty [33]. However, even with a conversion factor lower than the 
one used in our study the values remain significantly lower for CTCA. The advantage 
of prospective ECG-triggering as a new CTCA protocol to reduce E lies in its 
universal applicability. In fact, this is not limited to the 64-slice CT scanners but can 
be implemented into the latest (dual-source) and future scanner generations such as 
those with 320 slices allowing full coverage of the heart in 1 rotation. The following 
technical limitations of CTCA have to be considered: Image quality is affected by 
coronary calcification, motion artifacts and body-mass index [35]. Furthermore, sinus 
rhythm and heart rate control is mandatory for prospective ECG-triggering [36], 
explaining the frequent betablocker administration in this study. In addition, as the 
acquisition is limited to one phase the use of prospective ECG-triggering does not 
allow functional assessment of the left ventricle. Of note a substantial fraction of 
consented patients had to be excluded for medical reasons. These contraindications, 
however, such as renal dysfunction or iodine allergy equally apply to spiral scanning 
and, therefore, do not represent specific limitations of prospective ECG-triggered 
CTCA. Moreover, in contrast to some other centres we do not routinely add 
unenhanced CT for calcium scoring to our CTCA, because there is no evidence 
supporting that the additional radiation dose from calcium score is justified by an 
improvement in the accuracy of CTCA [1]. Thus, we did not perform a calcium score 
scan in the present study which has contributed to the low effect radiation dose of the 
CTCA. 
Although the relatively small population in the present study may limit the power of 
the accuracy analysis for CTCA vs. invasive CA this was not the primary goal of the 
study, which aimed at comparing the effective radiation dose of both techniques.  
CONCLUSIONS 
Low-dose CTCA allows evaluation of CAD with high accuracy, but significantly less 
effective radiation dose to patients compared to diagnostic invasive CA. 
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FIGURE LEGENDS: 
Figure 1: 
Effective radiation doses for each individual patient from othe two different methods, 
i.e. diagnostic invasive coronary angiography (CA) and CT coronary angiography 
(CTCA).  
 
Figure 2: 
Comparison of mean effective radiation dose (± standard deviation) of diagnostic 
invasive coronary angiography (CA) and CT coronary angiography (CTCA). 
 
Figure 3: 
Multiple calcified an uncalcified coronary lesions of an left descending artery are 
visualized on an angiographic view by CT coronary angiography (A) and on an 
invasive coronary angiography image with matching angulations (B). The arrow head 
indicates the most severs lesion in (A) and (B) as well as on the 3 dimensional 
volume rendered image (C). The mean effective radiation dose was 2.1 mSv for CT 
and 7.3 mSv for invasive coronary angiography. 
 
Figure 4: 
Left descending artery without coronary lesions is visualized on an angiographic view 
by CT coronary angiography (A), on an invasive coronary angiography image with 
matching angulations (B) and on the 3 dimensional volume rendered image (C). The 
mean effective radiation dose was 1.1 mSv for CT and 5.9 mSv for invasive coronary 
angiography. 
 
Figure 5: 
Impact of CT coronary angiography (CTCA) on pre-test probabilities of significant 
coronary artery disease (CAD). 1calculated using the Duke Clinical Score. 
2 calculated using Bayesian statistics (post-test odds = pretest odds x likelihood ratio).
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TABLES 
Table 1 Effective radiation dose: CTCA versus invasive CA 
 CTCA  CA   
BMI n Current (mA) 
Voltage 
(kV) 
DLP 
(mGy x cm) 
Radiation dose 
(mSv)  
DAP 
(mGy x cm2) 
Radiation dose 
(mSv) 
 
p 
all 42   122.4 ± 42.1 2.1 ± 0.7  38.7 ± 20.1 8.5 ± 4.4  <0.001* 
<22.5 kg/cm2 5 450 100 69.8 ± 10.1 1.2 ± 0.2  24.9 ± 20.5 5.5 ± 4.5  0.008* 
22.5-25 kg/cm2 15 500 100 86.5 ± 13.3 1.5 ± 0.2  33.0 ± 15.6 7.3 ± 3.4  <0.001* 
25-27.5 kg/cm2 6 550 120 152.6 ± 0.3 2.6 ± 0.0  42.2 ± 22.9 9.3 ± 5.0  0.002* 
27.5-30 kg/cm2 11 600 120 155.4 ± 19.7 2.6 ± 0.3  39.5 ± 15.5 8.7 ± 3.4  <0.001* 
>30 kg/cm2 5 650 120 173.8 ± 22.5 3.0 ± 0.4  63.4 ± 21.3 14.0 ± 4.70  0.008* 
CTCA computed tomography coronary angiography; ICA invasive coronary angiography; BMI body mass index;  
DLP dose length product; DAP dose area product 
* Bonferroni-adjusted level of significance was p<0.0083  
 
 
 
 
 
 
 
 
 
 o
n
 18 August 2009 
heart.bmj.com
D
ow
nloaded from
 
 17
 
 
 
Pretest 
Probability n TP FP TN FN Sens Spec PPV NPV Accuracy +LR -LR 
Per Patient  42 23 2 17 0 100 90 92 100 95 9.50 0 
Low 16 7 3 1 3 0 100 75 75 100 86 4.00 0 
Intermediate 52 22 13 0 9 0 100 100 100 100 100 NA 0 
High 87 13 7 1 5 0 100 83 100 88 92 6.00 0 
 
          
 
  
Per Vessel -- 168 49 6 110 3 94 95 89 95 95 18.22 0.06 
Low -- 28 7 3 17 1 88 85 70 94 86 5.83 0.15 
Intermediate -- 88 28 2 57 1 97 97 93 98 97 28.48 0.04 
High -- 52 14 1 36 1 93 97 93 97 96 34.53 0.07 
TP true positive, TN true negative, FP false positive, FN false negative, Sens sensitivity, Spec specificity 
PPV positive predictive value, NPV negative predictive value, LR likelihood ratio, NA not available 
 
Table 2 Diagnostic Accuracy and Predictive Value for CTCA 
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